Bechtle AG (0DPM)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 35.57 |
|---|---|
| 52-week range | 24.60 – 45.12 |
| Return, 1 month / 3 months | +5.9% / +9.7% |
| Return, 1 year / 3 years | −0.2% / −9.7% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 40.6% |
| Worst drawdown (1 year) | -42.6% |
| Average daily value traded | 0.21M EUR |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bechtle AG is a German information technology company based in Neckarsulm. It supplies computers, servers, networking equipment and software to business and public-sector customers, and it provides services such as IT consulting, system integration, managed services and training. Its customers range from small and mid-sized firms to large organisations and government bodies, mainly in Germany and other European countries. The company combines hardware and software sales with support and service work for its clients.
On this site Bechtle AG appears as a stock on the London Stock Exchange (UK), code 0DPM, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bechtle AG (0DPM) trades on the London Stock Exchange in UK. It last closed at EUR 35.57 on 27 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 2,084 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.2% and over the last three months it rose 9.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.2% | ||
| From 52-week high | -20.7% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.7% | ||
| 6-month return | 24.6% | ||
| 12-month return, skipping the last month | -5.8% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.6% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | +5.9% |
| 3 months | +9.7% |
| 6 months | +24.6% |
| 1 year | −0.2% |
| 3 years | −9.7% |
| 5 years | −40.3% |
Signals
| 50-day / 200-day average | 35.15 / 33.17 |
|---|---|
| Golden / death cross (60 days) | Golden, 31 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Jun 2026 | EUR 0.7000 |
| 28 May 2025 | EUR 0.7000 |
| 12 Jun 2024 | EUR 0.7000 |
| 26 May 2023 | EUR 0.6500 |
| 1 Jun 2022 | EUR 0.5500 |
| 16 Jun 2021 | EUR 1.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.